These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2999543)

  • 21. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T; Ohno M; Ueki S
    Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
    Stein C; Millan MJ; Yassouridis A; Herz A
    Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.
    Herrero JF; Headley PM
    Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory activity of mu- and kappa-selective opioid agonists.
    Taub DD; Eisenstein TK; Geller EB; Adler MW; Rogers TJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):360-4. PubMed ID: 1846441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat.
    Bhargava HN; Matwyshyn G; Ramarao P
    Gen Pharmacol; 1991; 22(3):429-34. PubMed ID: 1651266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
    Culpepper-Morgan J; Kreek MJ; Holt PR; LaRoche D; Zhang J; O'Bryan L
    Life Sci; 1988; 42(21):2073-7. PubMed ID: 2838706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN; Veeranna ; Reddy PL; Bhargava HN
    Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding.
    Jenck F; Quirion R; Wise RA
    Brain Res; 1987 Oct; 423(1-2):39-44. PubMed ID: 2823993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure.
    Negus SS; Picker MJ; Dykstra LA
    NIDA Res Monogr; 1989; 95():518-9. PubMed ID: 2561845
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
    Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of naloxone, morphine and kappa-opioid receptor agonists on hypoxia/hypoglycemia-induced reduction of 2-deoxyglucose uptake in hippocampal slices from U-50,488H-tolerant rats.
    Shibata S; Tominaga K; Watanabe S
    Neurosci Lett; 1994 Dec; 182(2):155-8. PubMed ID: 7715801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L; Rivière PJ; Pascaud X; Junien JL
    Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats.
    Adamson WT; Windh RT; Blackford S; Kuhn CM
    Endocrinology; 1991 Aug; 129(2):959-64. PubMed ID: 1649751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of kappa opiate agonists on palatable food consumption in non-deprived rats, with and without food preloads.
    Jackson A; Cooper SJ
    Brain Res Bull; 1985 Oct; 15(4):391-6. PubMed ID: 2998563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.